page_title: Carlo M. Croce
section_title: Discoveries and awards
hierarchical_section_title: Carlo M. Croce / Discoveries and awards
caption_attribution_description: English: Carlo M Croce receiving the InBev-Baillet Latour Prize for Outstanding Human Value in the Arts and Sciences from Her Majesty Queen Mathilde of Belgium in 2013
context_page_description: Carlo Maria Croce is an Italian-American professor of medicine at Ohio State University, specializing in oncology and the molecular mechanisms underlying cancer. Croce and his research have attracted public attention because of multiple allegations of scientific misconduct.
context_section_description: Croce and his research team discovered the juxtaposition of the human immunoglobulin genes to the MYC oncogene and the deregulation of MYC in Burkitt lymphoma; the MLL gene involved in acute leukemias; the TCL1A gene associated with T-cell leukemias; and cloned, named and characterized the BCL2 gene involved in follicular lymphoma. Croce also uncovered early events involved in the pathogenesis of lung, nasopharyngeal, head and neck, esophageal, gastrointestinal and breast cancers.
  In 2006 Croce received the Clowes Memorial Award from the American Association for Cancer Research for his discoveries of the molecular mechanisms of leukemia. In 2010, he was elected a fellow of the American Academy of Arts and Sciences. In 2017, Croce received the Margaret Foti Award from the AACR for Leadership and Extraordinary Achievements in Cancer Research.
caption: The 2013 prize of the Artois-Baillet Latour Foundation is given by The Queen of the Belgians to Croce
exif: {}